Effects of bromocriptine in peripartum cardiomyopathy: a systematic review and meta-analysis

射血分数 医学 围产期心肌病 不利影响 内科学 溴隐亭 置信区间 心肌病 心脏病学 相对风险 心力衰竭 激素 催乳素
作者
Angkawipa Trongtorsak,Veraprapas Kittipibul,Sunita Mahabir,Michel Ibrahim,Garly Rushler Saint Croix,Gabriel A. Hernandez,Sandra Chaparro
出处
期刊:Heart Failure Reviews [Springer Science+Business Media]
卷期号:27 (2): 533-543 被引量:17
标识
DOI:10.1007/s10741-021-10185-8
摘要

Peripartum cardiomyopathy (PPCM) is a rare but potentially life-threatening form of heart failure (HF). Bromocriptine, a dopamine D2 agonist, has been used as an adjunctive treatment for PPCM with controversial benefits. A comprehensive literature search was conducted through June 2021. We included studies comparing the outcomes of PPCM with or without bromocriptine use. Pooled risk ratio (RR) with 95% confidence intervals (CI) and I2 statistics were calculated. Composite major adverse outcomes were defined by a composite of death, need for advanced HF therapies, persistent New York Heart Association (NYHA) functional class III/V, or left ventricular ejection fraction (LVEF) ≤ 35% at 6-month follow-up. LVEF recovery was defined by improvement of LVEF to more than 50%. Eight studies (two randomized-controlled, six observational) involving 593 PPCM patients were included. Bromocriptine use was associated with significantly higher survival (91.6% vs. 83.9%, RR 1.11 p = 0.02). Baseline LVEF was not significantly different between the groups. LVEF at follow-up was significantly higher in the bromocriptine group (53.3% vs. 41.8%, p < 0.001). There was no significant association between bromocriptine use and lower composite major adverse outcomes (13.7% vs. 33.3%, RR 0.60 p = 0.54) or LVEF recovery (46.9% vs. 46.8%, RR 0.94 p = 0.74). In conclusion, the addition of bromocriptine to standard HF treatment in PPCM was associated with significantly higher survival and higher LVEF improvement. No association with lower composite adverse clinical outcomes or LVEF recovery was seen. The findings, although encouraging, warrant larger randomized-controlled studies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
跳脚的虾完成签到 ,获得积分10
1秒前
JSEILWQ完成签到 ,获得积分10
5秒前
innocent完成签到,获得积分10
8秒前
彩色靖儿完成签到 ,获得积分10
13秒前
岚12完成签到 ,获得积分10
15秒前
JUAN完成签到,获得积分10
19秒前
陶醉的翠霜完成签到 ,获得积分10
20秒前
Novice6354完成签到 ,获得积分10
22秒前
心灵美绝施完成签到 ,获得积分10
26秒前
大雪完成签到 ,获得积分10
32秒前
呆橘完成签到 ,获得积分10
33秒前
22222应助yhm7426采纳,获得50
33秒前
34秒前
life的半边天完成签到 ,获得积分10
40秒前
灵巧的十八完成签到 ,获得积分10
41秒前
空曲完成签到 ,获得积分10
46秒前
小文子完成签到 ,获得积分10
47秒前
可可可爱完成签到 ,获得积分10
48秒前
鹏826完成签到 ,获得积分0
50秒前
zjq完成签到 ,获得积分10
50秒前
李爱国应助故意的鼠标采纳,获得10
51秒前
牧绯完成签到,获得积分10
54秒前
55秒前
Superman完成签到 ,获得积分10
59秒前
乘风破浪完成签到 ,获得积分10
59秒前
贝贝完成签到 ,获得积分10
59秒前
Arctic完成签到,获得积分10
1分钟前
调皮蛋完成签到,获得积分10
1分钟前
reset完成签到 ,获得积分10
1分钟前
suodeheng完成签到,获得积分20
1分钟前
SY15732023811完成签到 ,获得积分10
1分钟前
www完成签到 ,获得积分10
1分钟前
leo完成签到 ,获得积分10
1分钟前
天天快乐应助帅气的宛凝采纳,获得10
1分钟前
RandyChen完成签到,获得积分10
1分钟前
kehe!完成签到 ,获得积分0
1分钟前
Nemo完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
英勇海完成签到 ,获得积分10
1分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968559
求助须知:如何正确求助?哪些是违规求助? 3513391
关于积分的说明 11167370
捐赠科研通 3248808
什么是DOI,文献DOI怎么找? 1794465
邀请新用户注册赠送积分活动 875116
科研通“疑难数据库(出版商)”最低求助积分说明 804664